How Do We Handle Hyperuricemia?
Achieving Target Serum Uric Acid Levels in Gout

Podcast #1:  Updated Guidelines for Gout Treatment: Pearls for Practice

In this educational activity, 2 gout experts review key pearls from evidence-based guidelines for gout management, including those from the ACP, ACR, and EULAR. Key differences among the various recommendations relative to the long-term management of hyperuricemia are discussed in detail, and the implications for clinical practice are reviewed.

Roundtable: Identifying and Addressing Persistent Hyperuricemia in Gout

Two rheumatologists who specialize in the treatment of gout review evidence-based strategies for addressing hyperuricemia. Topics of discussion include setting individualized treatment targets, nonpharmacologic approaches to treatment, available urate-lowering therapies and the risks/benefits of each, and novel, combination approaches to treating hyperuricemia.

Podcast #2: Engaging the Patient with Gout in Long-Term Treatment

The faculty discuss the importance of patient education relative to effectively managing hyperuricemia. Practical strategies for engaging patients with gout in treatment decisions are discussed, as are methods for fostering patient adherence over the long term.

Intended Audience

Primary care and internal medicine clinicians (MDs/DOs, physician assistants [PAs], nurse practitioners [NPs] and nurses); rheumatologists

Learning Objectives:

  • Describe the complications associated with uncontrolled hyperuricemia
  • Review markers for quality care in patients with gout
  • Review key differences in evidence-based guidelines for gout management disseminated by leading national medical organizations
  • Implement effective urate-lowering therapy in patients with gout

FACULTY

Paul P. Doghramji, MD, FAAFP
Family Physician, Collegeville Family Practice
  Medical Director for Health Services
Ursinus College
Collegeville, PA

Michael Pillinger, MD
Chief of Rheumatology, VA NY Harbor
  Health Care System
Director, Clinical and Translational Science
  Institute Education and Careers Unit of
  New York University
New York, NY

Naomi Schlesinger, MD
Professor of Medicine
Chief, Division of Rheumatology
Department of Medicine
Rutgers - Robert Wood Johnson
  Medical School
New Brunswick, NJ

Robert Terkeltaub, MD
Professor of Medicine
Division of Rheumatology and Immunology
University of California San Diego
San Diego, CA

Arthur Weaver, MD, MS, FACP, MACR
Clinical Professor of Medicine Emeritus
Department of Medicine, Section of
  Rheumatology University of Nebraska
  Medical Center
Omaha, NE

Provided by


In Collaboration with

These activities are supported by an
educational grant from
Ironwood Pharmaceuticals, Inc..